Childhood Vaccinations and Type 1 Diabetes.

Szczegóły
Abstrakt

Tytuł:: Childhood Vaccinations and Type 1 Diabetes.
Autorzy:: Esposito S; Paediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, Italy.
Mariotti Zani E; Paediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, Italy.
Torelli L; Paediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, Italy.
Scavone S; Paediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, Italy.
Petraroli M; Paediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, Italy.
Patianna V; Paediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, Italy.
Predieri B; Pediatric Unit, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
Iughetti L; Pediatric Unit, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
Principi N; Paediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, Italy.
Źródło:: Frontiers in immunology [Front Immunol] 2021 Aug 26; Vol. 12, pp. 667889. Date of Electronic Publication: 2021 Aug 26 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
Język:: English
Imprint Name(s):: Original Publication: [Lausanne : Frontiers Research Foundation]
MeSH Terms:: Vaccination*/adverse effects
Diabetes Mellitus, Type 1/*immunology
Viral Vaccines/*administration & dosage
Virus Diseases/*prevention & control
Diabetes Mellitus, Type 1/epidemiology ; Humans ; Immunocompromised Host ; Immunogenicity, Vaccine ; Risk Assessment ; Risk Factors ; Vaccines, Attenuated/administration & dosage ; Vaccines, Attenuated/adverse effects ; Viral Vaccines/adverse effects ; Virus Diseases/epidemiology ; Virus Diseases/immunology ; Virus Diseases/virology
References:: Arch Intern Med. 2004 May 10;164(9):989-93. (PMID: 15136308)
JAMA Pediatr. 2019 Mar 1;173(3):280-282. (PMID: 30667473)
BMJ. 2011 Feb 03;342:d35. (PMID: 21292721)
Med Sci Monit. 2002 Jul;8(7):CR516-9. (PMID: 12118201)
Diabetologia. 2014 Oct;57(10):2193-200. (PMID: 25047648)
Diabet Med. 1993 Jul;10(6):521-3. (PMID: 8395988)
JAMA Pediatr. 2020 May 1;174(5):455-462. (PMID: 32150236)
Diabetes Care. 2002 Oct;25(10):1778-83. (PMID: 12351477)
Diabetes Care. 2010 Jul;33(7):1491-3. (PMID: 20587722)
Exp Ther Med. 2015 Aug;10(2):693-698. (PMID: 26622377)
J Infect Dis. 2020 Sep 1;222(7):1076-1083. (PMID: 32249284)
Int J Mol Sci. 2020 Apr 22;21(8):. (PMID: 32331412)
Front Endocrinol (Lausanne). 2015 Sep 14;6:134. (PMID: 26441826)
Genes (Basel). 2017 Feb 16;8(2):. (PMID: 28212332)
Vaccine. 2000 Nov 22;19(7-8):680-3. (PMID: 11115688)
J Infect. 2020 Aug;81(2):e16-e25. (PMID: 32335169)
J Pediatr Endocrinol Metab. 2003 Apr-May;16(4):495-508. (PMID: 12793601)
Diabetologia. 2015 Nov;58(11):2592-5. (PMID: 26253765)
Pediatr Endocrinol Rev. 2013 Dec;11(2):161-6. (PMID: 24575551)
Clin Microbiol Rev. 2006 Jan;19(1):80-94. (PMID: 16418524)
Chest. 2017 Jul;152(1):174-180. (PMID: 28434937)
J Clin Virol. 2017 Nov;96:26-31. (PMID: 28934695)
J Immunol. 2010 Feb 15;184(4):2204-10. (PMID: 20083660)
Hum Vaccin Immunother. 2013 Sep;9(9):2002-6. (PMID: 23787761)
Diabet Med. 1996 Jul;13(7):630-3. (PMID: 8840096)
Diabetes Care. 2020 Nov;43(11):e170-e171. (PMID: 32816997)
JAMA. 2016 May 3;315(17):1899-901. (PMID: 27139064)
Sci Rep. 2019 Jun 13;9(1):7727. (PMID: 31197227)
Nat Rev Endocrinol. 2019 Nov;15(11):635-650. (PMID: 31534209)
Pediatr Endocrinol Diabetes Metab. 2009;15(4):227-32. (PMID: 20455416)
J Postgrad Med. 2011 Jan-Mar;57(1):78-81. (PMID: 21206113)
Clin Infect Dis. 2005 Aug 1;41(3):281-8. (PMID: 16007521)
Pediatrics. 2001 Dec;108(6):E112. (PMID: 11731639)
PLoS One. 2013 Apr 10;8(4):e60057. (PMID: 23593162)
Diabetes Care. 2018 Oct;41(10):2127-2135. (PMID: 30104296)
Am J Epidemiol. 1991 May 15;133(10):1024-31. (PMID: 1852097)
JAMA Pediatr. 2013 Sep;167(9):808-15. (PMID: 23836309)
Int J Endocrinol. 2015;2015:234358. (PMID: 26074959)
Autoimmun Rev. 2016 Jul;15(7):644-8. (PMID: 26903475)
Nature. 1992 Jul 9;358(6382):155-7. (PMID: 1377368)
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3988-91. (PMID: 11274421)
J Diabetes Res. 2018 Nov 8;2018:7457269. (PMID: 30533447)
Clin Exp Immunol. 2013 Feb;171(2):171-85. (PMID: 23286944)
Diabetologia. 2009 Feb;52(2):369-70; author reply 373. (PMID: 19034414)
Hum Vaccin Immunother. 2012 Apr;8(4):448-52. (PMID: 22370513)
Diabetes Care. 2000 Oct;23(10):1516-26. (PMID: 11023146)
Vaccine. 2009 Aug 27;27(39):5357-62. (PMID: 19607951)
J Intern Med. 2014 Apr;275(4):398-408. (PMID: 24206418)
Infect Dis Clin North Am. 1997 Sep;11(3):735-50. (PMID: 9378933)
Rev Med Microbiol. 2019 Jan;30(1):1-17. (PMID: 30662163)
Pediatr Infect Dis J. 2019 May;38(5):539-541. (PMID: 30986791)
Diabetes Care. 2000 Jun;23(6):744-9. (PMID: 10840989)
Trends Microbiol. 2003 Mar;11(3):101-5. (PMID: 12648936)
BMJ. 1999 Oct 23;319(7217):1133. (PMID: 10531116)
Diabetes. 2016 Jan;65(1):285-96. (PMID: 26450993)
J Med Virol. 2002 Mar;66(3):340-50. (PMID: 11793386)
Clin Immunol. 2002 Jun;103(3 Pt 1):249-59. (PMID: 12173299)
JAMA Pediatr. 2013 Sep;167(9):800-7. (PMID: 23818010)
J Pediatr Endocrinol Metab. 2002 Apr;15(4):389-95. (PMID: 12008685)
J Clin Invest. 1994 Nov;94(5):2125-9. (PMID: 7962558)
Diabetologia. 1987 Jun;30(6):397-401. (PMID: 3678660)
Diabetes. 2000 Aug;49(8):1319-24. (PMID: 10923632)
BMC Med. 2015 Mar 17;13:53. (PMID: 25857236)
Infect Dis Clin North Am. 2001 Jun;15(2):407-21, viii. (PMID: 11447703)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Arch Dis Child. 1998 Jan;78(1):54-7. (PMID: 9534677)
Endocr J. 2008 Jul;55(3):561-4. (PMID: 18520103)
Acta Biomed. 2020 Sep 07;91(3):e2020033. (PMID: 32921727)
JAMA Pediatr. 2020 Apr 1;174(4):383-385. (PMID: 31961393)
FEMS Immunol Med Microbiol. 1999 Dec;26(3-4):259-65. (PMID: 10575137)
Clin Immunol. 2015 Aug;159(2):143-53. (PMID: 26051037)
Diabetes Care. 2021 Mar;44(3):699-706. (PMID: 33419932)
Diabetologia. 2016 Feb;59(2):237-43. (PMID: 26564178)
Vaccine. 2019 Mar 28;37(14):1938-1944. (PMID: 30827738)
Autoimmun Rev. 2014 Jul;13(7):736-41. (PMID: 24468416)
Clin Vaccine Immunol. 2016 Nov 4;23(11):873-877. (PMID: 27581437)
Lancet. 1998 Feb 21;351(9102):568-9. (PMID: 9492780)
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17040-5. (PMID: 17942684)
Diabetologia. 1991 Mar;34(3):176-81. (PMID: 1884889)
Pediatr Diabetes. 2018 May;19(3):512-519. (PMID: 29094435)
Front Immunol. 2018 May 17;9:1086. (PMID: 29868031)
Autoimmun Rev. 2013 Mar;12(5):633-7. (PMID: 23277162)
Curr Diabetes Rev. 2020;16(5):442-449. (PMID: 31657690)
Autoimmunity. 1996;24(3):137-45. (PMID: 9020406)
Diabetes. 2002 Dec;51(12):3353-61. (PMID: 12453886)
Hum Vaccin Immunother. 2015;11(1):58-62. (PMID: 25483516)
Indian J Endocrinol Metab. 2012 Mar;16 Suppl 1:S27-36. (PMID: 22701840)
BMJ. 1999 May 1;318(7192):1169-72. (PMID: 10221937)
Int J Antimicrob Agents. 2008 Feb;31 Suppl 1:S54-7. (PMID: 18054467)
J Exp Med. 1995 Jun 1;181(6):1945-8. (PMID: 7539032)
Diabet Med. 2011 Dec;28(12):1530-6. (PMID: 21916971)
Pediatr Infect Dis J. 2017 Jul;36(7):674-675. (PMID: 28399059)
Pneumonol Alergol Pol. 2015;83(5):401-8. (PMID: 26379004)
Vaccine. 2017 Aug 24;35(36):4761-4768. (PMID: 28750853)
Diabetes Care. 1997 May;20(5):767-72. (PMID: 9135940)
Contributed Indexing:: Keywords: autoimmunity; infection; type 1 diabetes; vaccination; vaccine
Substance Nomenclature:: 0 (Vaccines, Attenuated)
0 (Viral Vaccines)
Entry Date(s):: Date Created: 20210913 Date Completed: 20211020 Latest Revision: 20231107
Update Code:: 20240105
PubMed Central ID:: PMC8427438
DOI:: 10.3389/fimmu.2021.667889
PMID:: 34512622
: Czasopismo naukowe

Full Text Finder

Type 1 diabetes (T1D) is the most common paediatric endocrine disease, and its frequency has been found to increase worldwide. Similar to all conditions associated with poorly regulated glucose metabolism, T1D carries an increased risk of infection. Consequently, careful compliance by T1D children with schedules officially approved for child immunization is strongly recommended. However, because patients with T1D show persistent and profound limitations in immune function, vaccines may evoke a less efficient immune response, with corresponding lower protection. Moreover, T1D is an autoimmune condition that develops in genetically susceptible individuals and some data regarding T1D triggering factors appear to indicate that infections, mainly those due to viruses, play a major role. Accordingly, the use of viral live attenuated vaccines is being debated. In this narrative review, we discussed the most effective and safe use of vaccines in patients at risk of or with overt T1D. Literature analysis showed that several problems related to the use of vaccines in children with T1D have not been completely resolved. There are few studies regarding the immunogenicity and efficacy of vaccines in T1D children, and the need for different immunization schedules has not been precisely established. Fortunately, the previous presumed relationship between vaccine administration and T1D appears to have been debunked, though some doubts regarding rotavirus vaccines remain. Further studies are needed to completely resolve the problems related to vaccine administration in T1D patients. In the meantime, the use of vaccines remains extensively recommended in children with this disease.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2021 Esposito, Mariotti Zani, Torelli, Scavone, Petraroli, Patianna, Predieri, Iughetti and Principi.)

Informacja